You are here:

Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Diabetes

Canagliflozin in combination therapy for treating type 2 diabetes

Technology appraisal guidance
Reference number: TA315
Published: 25 June 2014

Guidance
Tools and resources
Information for the public
Evidence
History

Diabetes (type 2) - canagliflozin: FAD document

Diabetes (type 2) - canagliflozin: FAD document

Diabetes (type 2) - canagliflozin: FAD document
16 May 2014
(456.94 Kb 13 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 14 May 2014